Most people do their best to avoid mosquitoes. But this summer Rollie Clem will play the wary host to his own homegrown swarm of Aedes aegypti, the yellow fever mosquito. He’s made a room ready for them, and even a menu.
Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S. McIntosh from the University of Nottingham in a paper published this week in the open-access journal PLoS Pathogens.
Developing new strategies to prevent and control yellow fever and dengue fever has become more possible with the completion of the first draft of the genome sequence of Aedes aegypti mosquito by scientists led by Vishvanath Nene at The Institute for Genomic Research (TIGR) and David Severson at the University of Notre Dame.
The head of the decision-making body of the United Nations World Health Organization today stressed the importance of rapid, world-wide sharing of knowledge on diseases, as he opened the annual policy meeting in Geneva, Switzerland.
A thin strip that dissolves in the mouth like a popular breath-freshener could someday provide life-saving rotavirus vaccine to infants in impoverished areas. The innovative drug-delivery system was developed by Johns Hopkins undergraduate biomedical engineering students.
On Sunday, 13 May 2007, hundreds of thousands of people worldwide will walk together over a 24-hour period in each of the planet?s time zones, to deliver a message: child hunger has no place in this world and citizens across the globe can put an end to it.
Tulane general internist Jeffrey Wiese reminds us that summer heat can strike with little warning. Children, the elderly, overweight persons and people on certain medications need to take extra precautions because they are especially vulnerable to the effects of heat.
U.S. and Indian health officials have renewed the Indo-U.S. Vaccine Action Program (VAP), a 20-year-old bilateral collaboration supporting research on vaccines, immunology and related biomedical issues. The VAP aims to reduce the burden of vaccine-preventable diseases of public health significance in India, the United States and other parts of the world, and to promote vaccines as one of the most cost-effective health technologies.
US Bill Clinton announced new agreements that significantly lower the price of AIDS treatment for second-line anti-retroviral drugs (ARVs), drugs required in patients who develop resistance to first-line treatment and which currently cost 10 times the price of first-line therapy.
AIDS Healthcare Foundation (AHF), the US? largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, lauded the Government of Thailand for its vow to continue with plans to issue compulsory licenses for the manufacturing and importing of generic versions of lifesaving drugs, including AIDS drugs, despite the fact that the office of United States Trade Representative (USTR), earlier this week elevated Thailand to its ?Priority Watch? List.